North Bethesda, MD (PRWEB) January 11, 2022 The International Society for Pharmaceutical Engineering (ISPE) announced experts from leading pharmaceutical
Catalent is reporting that the technology transfer for the manufacture of BrainStorm Cell Therapeutics’ autologous cellular therapy at its facility in Houston, Texas has been finalized.